General Framework for the Quantitative Prediction of CYP3A4-Mediated Oral Drug Interactions Based on the AUC Increase by Coadministration of Standard Drugs

By Ohno Yoshiyuki   Hisaka Akihiro   Suzuki Hiroshi  

Clinical Pharmacokinetics, Vol. 46, Iss. 8, 2007-01 ,pp. : 681-696

Adis International

Access to resources Recommend Favorite

Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S.   Galetin Aleksandra   Hallifax David   Houston J. Brian  

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite

In Silico Predictions and In Vivo Results of Drug–Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 364-373

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Vivo Animal Models for Investigating Potential CYP3A- and Pgp-Mediated Drug-Drug Interactions

By  

Current Drug Metabolism, Vol. 7, Iss. 7, 2006-10 ,pp. : 687-704

Bentham Science Publishers

Access to resources Recommend Favorite

Predicting Drug-Drug Interactions Involving the Inhibition of Intestinal CYP3A4 and P-Glycoprotein

By  

Current Drug Metabolism, Vol. 11, Iss. 9, 2010-11 ,pp. : 762-777

Bentham Science Publishers

Access to resources Recommend Favorite